SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,197,616 | -15.3% | 51,800 | -3.9% | 0.00% | -25.0% |
| Q2 2023 | $1,413,258 | -27.3% | 53,900 | -28.6% | 0.00% | -33.3% |
| Q1 2023 | $1,943,370 | -37.1% | 75,500 | -36.4% | 0.01% | -40.0% |
| Q4 2022 | $3,089,130 | -6.4% | 118,767 | +2.7% | 0.01% | -9.1% |
| Q3 2022 | $3,301,000 | -58.5% | 115,699 | -64.1% | 0.01% | -57.7% |
| Q2 2022 | $7,945,000 | +63.8% | 322,692 | +312.4% | 0.03% | +160.0% |
| Q4 2021 | $4,850,000 | -47.7% | 78,250 | -46.5% | 0.01% | -52.4% |
| Q3 2021 | $9,276,000 | +583.6% | 146,221 | +788.1% | 0.02% | +600.0% |
| Q2 2021 | $1,357,000 | -66.5% | 16,464 | -70.1% | 0.00% | -72.7% |
| Q1 2021 | $4,052,000 | +77.8% | 55,083 | +75.3% | 0.01% | +57.1% |
| Q4 2020 | $2,279,000 | – | 31,430 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |